IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q1 2026 Holdings

Filed 2026-05-07 | 2 holdings | $266.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Maze Therapeutics, Inc.(MAZE)COM578784100$133.5M4,473,95850.0%
Tango Therapeutics, Inc.(TNGX)COM87583X109$133.4M6,374,57450.0%